| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,850 | 10,457 | 4,810 | | Cost of Revenue | 1,635 | 2,577 | 900 | | | Gross Profit | 7,215 | 7,880 | 3,911 | | | Operating Expenses | | Research Development | 19,079 | 21,958 | 25,974 | | Selling General and Administrative | 24,384 | 26,044 | 21,289 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (36,249) | (40,122) | (43,352) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,990) | (1,706) | 1,873 | | Earnings Before Interest And Taxes | (42,239) | (41,665) | (41,480) | | Interest Expense |
-
| 584 | 511 | | Income Before Tax | (42,239) | (42,249) | (41,990) | | Income Tax Expense | (174) |
-
|
-
| | Minority Interest | 485 | 162 |
-
| | | | Net Income From Continuing Ops | (41,580) | (42,249) | (41,990) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (41,580) | (42,249) | (41,990) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($41,580) | ($42,249) | ($41,990) |
|
0.01% Nasdaq 
0.06 (9.23%) 
Income Statement
